Inter-Rater Reliability of the CASCADE Criteria: Challenges in Classifying Arteriopathies

Timothy J Bernard1, Lauren A Beslow2, Marilyn J Manco-Johnson2

  • 1From the Section of Child Neurology (T.J.B., J.A.-W., R.B.), Section of Hematology/Oncology/BMT (M.J.M.-J.), Hemophilia and Thrombosis Center, Department of Pediatrics (T.J.B., M.J.M.-J., J.A.-W., A.H.), Department of Pediatrics (T.J.B, M.J.M-J, J.A-W., R.B.), Department of Biostatistics and Informatics, School of Public Health (D.W.), and Department of Neurology (S.P.), University of Colorado, Aurora; Division of Child Neurology (L.A.B.), Department of Pediatrics (L.A.B.), and Department of Neurology (L.A.B.), Yale School of Medicine, New Haven, CT; University of Washington (C.A.L.); Department of Pediatrics (W.L., E.S.R.) and Department of Neurology (W.L., E.S.R.), The Ohio State University and Nationwide Children's Hospital, Columbus; Hospital for Sick Children, University of Toronto, Ontario, Canada (G.d.V.); Division of Hematology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD (N.A.G.); All Children's Research Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL (N.A.G.); Division of Pediatric Neurology, Department of Pediatrics (M.M.D.) and Department of Neurology and Neurotherapeutics (M.M.D.), UT Southwestern Medical Center, Dallas, TX; Division of Neurology, University of California, San Francisco (H.J.F.); Rheumatology Clinic, Department of Pediatrics, Alberta Children's Hospital, Cumming School of Medicine, University of Calgary, Canada (S.M.B.); Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center (L.C.J.); Calgary Pediatric Stroke Program, Division of Neurology, Alberta Children's Hospital, University of Calgary, Canada (A.K.); and Department Neurology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine (R.N.I.). timothy.bernard@ucdenver.edu.

Stroke
|September 17, 2016
PubMed

Insights

The CASCADE criteria show moderate reliability for classifying childhood arterial ischemic stroke subtypes. Further refinement is needed for arteriopathic subtypes to improve consistency in research.

Area of Science:

  • Pediatric Neurology
  • Stroke Classification
  • Medical Diagnostics

Background:

  • Limited data exist on the reliability of classifying childhood arterial ischemic stroke (AIS) subtypes.
  • The International Pediatric Stroke Study (IPSS) developed the CASCADE criteria for standardized classification and evaluation of pediatric AIS.
  • Assessing the reliability of the CASCADE criteria is crucial for consistent research and clinical practice.

Purpose of the Study:

  • To determine the reliability of the CASCADE criteria in classifying pediatric arterial ischemic stroke subtypes.
  • To evaluate inter-rater agreement among experienced raters using the CASCADE criteria.

Main Methods:

  • Eight IPSS raters reviewed 64 pediatric AIS cases, classifying them using the CASCADE criteria.
  • Data included neuroimaging, clinical history, risk factors, and acute imaging.
  • Inter-rater reliability was measured using the unweighted κ statistic.

Main Results:

  • The CASCADE criteria demonstrated moderate overall inter-rater reliability (κ = 0.53).
  • High agreement was observed for cardioembolic (κ = 0.84) and bilateral cerebral arteriopathy (κ = 0.90) subtypes.
  • Lower agreement was found for aortic/cervical arteriopathy (κ = 0.36), unilateral FCA (κ = 0.49), and small vessel arteriopathy (κ = -0.012).

Conclusions:

  • The CASCADE criteria possess moderate reliability for use in multicenter pediatric stroke studies by trained raters.
  • Further refinement of arteriopathic subtype definitions is necessary to enhance reliability.
  • Improved subtype classification can reduce variability in research on childhood stroke risk factors, recurrence, and outcomes.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
692
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
580
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
895